Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 20, 2025Current Issues in Molecular BiologyOpen Access

Anti-TB Drugs for Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis: A Review

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKara LukasMDMO DANGCNClare Necas

Discussion

Loading...

Member takes

Overview

Review highlights new pharmacologic regimens and diagnostics for tuberculosis, suggesting improvements in treatment adherence.

Key Points

  • A 4-month rifapentine–moxifloxacin regimen is non-inferior to the 6-month standard for drug-sensitive TB.
  • Drug-resistant TB treatments with bedaquiline and others show efficacy but require careful monitoring for side effects.
  • Adjunctive therapies like metformin and statins may improve host immunity in TB patients.
  • Advancements in diagnostics, including whole genome sequencing, enable rapid detection of drug resistance.

Cite This Study

Lukas et al. (2025) studied this question.

synapsesocial.com/papers/68d43c87713b0b5dfea7c487https://doi.org/10.3390/cimb47090776
View Full Paper
Ask AI
Bookmark
Share